498 related articles for article (PubMed ID: 25311639)
1. Novel approaches for targeting the adenosine A2A receptor.
Yuan G; Gedeon NG; Jankins TC; Jones GB
Expert Opin Drug Discov; 2015 Jan; 10(1):63-80. PubMed ID: 25311639
[TBL] [Abstract][Full Text] [Related]
2. Complementarity between in silico and biophysical screening approaches in fragment-based lead discovery against the A(2A) adenosine receptor.
Chen D; Ranganathan A; IJzerman AP; Siegal G; Carlsson J
J Chem Inf Model; 2013 Oct; 53(10):2701-14. PubMed ID: 23971943
[TBL] [Abstract][Full Text] [Related]
3. Crystal structure of the adenosine A
Sun B; Bachhawat P; Chu ML; Wood M; Ceska T; Sands ZA; Mercier J; Lebon F; Kobilka TS; Kobilka BK
Proc Natl Acad Sci U S A; 2017 Feb; 114(8):2066-2071. PubMed ID: 28167788
[TBL] [Abstract][Full Text] [Related]
4. Integrating Pharmacophore into Membrane Molecular Dynamics Simulations to Improve Homology Modeling of G Protein-coupled Receptors with Ligand Selectivity: A2A Adenosine Receptor as an Example.
Zeng L; Guan M; Jin H; Liu Z; Zhang L
Chem Biol Drug Des; 2015 Dec; 86(6):1438-50. PubMed ID: 26072970
[TBL] [Abstract][Full Text] [Related]
5. Molecular docking screening using agonist-bound GPCR structures: probing the A2A adenosine receptor.
Rodríguez D; Gao ZG; Moss SM; Jacobson KA; Carlsson J
J Chem Inf Model; 2015 Mar; 55(3):550-63. PubMed ID: 25625646
[TBL] [Abstract][Full Text] [Related]
6. Could the presence of sodium ion influence the accuracy and precision of the ligand-posing in the human A
Margiotta E; Deganutti G; Moro S
J Comput Aided Mol Des; 2018 Dec; 32(12):1337-1346. PubMed ID: 30361971
[TBL] [Abstract][Full Text] [Related]
7. Adenosine A2A receptor as a drug discovery target.
de Lera Ruiz M; Lim YH; Zheng J
J Med Chem; 2014 May; 57(9):3623-50. PubMed ID: 24164628
[TBL] [Abstract][Full Text] [Related]
8. Affinity Mass Spectrometry-Based Fragment Screening Identified a New Negative Allosteric Modulator of the Adenosine A
Lu Y; Liu H; Yang D; Zhong L; Xin Y; Zhao S; Wang MW; Zhou Q; Shui W
ACS Chem Biol; 2021 Jun; 16(6):991-1002. PubMed ID: 34048655
[TBL] [Abstract][Full Text] [Related]
9. Recent Advances in the In-silico Structure-based and Ligand-based Approaches for the Design and Discovery of Agonists and Antagonists of A2A Adenosine Receptor.
Agrawal N; Chandrasekaran B; Al-Aboudi A
Curr Pharm Des; 2019; 25(7):774-782. PubMed ID: 30848185
[TBL] [Abstract][Full Text] [Related]
10. Bridging molecular docking to membrane molecular dynamics to investigate GPCR-ligand recognition: the human A₂A adenosine receptor as a key study.
Sabbadin D; Ciancetta A; Moro S
J Chem Inf Model; 2014 Jan; 54(1):169-83. PubMed ID: 24359090
[TBL] [Abstract][Full Text] [Related]
11. Allosteric interactions between agonists and antagonists within the adenosine A2A receptor-dopamine D2 receptor heterotetramer.
Bonaventura J; Navarro G; Casadó-Anguera V; Azdad K; Rea W; Moreno E; Brugarolas M; Mallol J; Canela EI; Lluís C; Cortés A; Volkow ND; Schiffmann SN; Ferré S; Casadó V
Proc Natl Acad Sci U S A; 2015 Jul; 112(27):E3609-18. PubMed ID: 26100888
[TBL] [Abstract][Full Text] [Related]
12. Selecting an optimal number of binding site waters to improve virtual screening enrichments against the adenosine A2A receptor.
Lenselink EB; Beuming T; Sherman W; van Vlijmen HW; IJzerman AP
J Chem Inf Model; 2014 Jun; 54(6):1737-46. PubMed ID: 24835542
[TBL] [Abstract][Full Text] [Related]
13. Allosteric mechanisms within the adenosine A2A-dopamine D2 receptor heterotetramer.
Ferré S; Bonaventura J; Tomasi D; Navarro G; Moreno E; Cortés A; Lluís C; Casadó V; Volkow ND
Neuropharmacology; 2016 May; 104():154-60. PubMed ID: 26051403
[TBL] [Abstract][Full Text] [Related]
14. The crystallographic structure of the human adenosine A2A receptor in a high-affinity antagonist-bound state: implications for GPCR drug screening and design.
Jaakola VP; Ijzerman AP
Curr Opin Struct Biol; 2010 Aug; 20(4):401-14. PubMed ID: 20538452
[TBL] [Abstract][Full Text] [Related]
15. Binding mode similarity measures for ranking of docking poses: a case study on the adenosine A2A receptor.
Anighoro A; Bajorath J
J Comput Aided Mol Des; 2016 Jun; 30(6):447-56. PubMed ID: 27334985
[TBL] [Abstract][Full Text] [Related]
16. Substructure-based virtual screening for adenosine A2A receptor ligands.
van der Horst E; van der Pijl R; Mulder-Krieger T; Bender A; Ijzerman AP
ChemMedChem; 2011 Dec; 6(12):2302-11. PubMed ID: 22021213
[TBL] [Abstract][Full Text] [Related]
17. Revisiting a receptor-based pharmacophore hypothesis for human A(2A) adenosine receptor antagonists.
Bacilieri M; Ciancetta A; Paoletta S; Federico S; Cosconati S; Cacciari B; Taliani S; Da Settimo F; Novellino E; Klotz KN; Spalluto G; Moro S
J Chem Inf Model; 2013 Jul; 53(7):1620-37. PubMed ID: 23705857
[TBL] [Abstract][Full Text] [Related]
18. Adenosine A2A Receptor as a Potential Drug Target - Current Status and Future Perspectives.
Al-Attraqchi OHA; Attimarad M; Venugopala KN; Nair A; Al-Attraqchi NHA
Curr Pharm Des; 2019; 25(25):2716-2740. PubMed ID: 31333093
[TBL] [Abstract][Full Text] [Related]
19. Design, synthesis, and biological evaluation of novel 2-((2-(4-(substituted)phenylpiperazin-1-yl)ethyl)amino)-5'-N-ethylcarboxamidoadenosines as potent and selective agonists of the A2A adenosine receptor.
Preti D; Baraldi PG; Saponaro G; Romagnoli R; Aghazadeh Tabrizi M; Baraldi S; Cosconati S; Bruno A; Novellino E; Vincenzi F; Ravani A; Borea PA; Varani K
J Med Chem; 2015 Apr; 58(7):3253-67. PubMed ID: 25780876
[TBL] [Abstract][Full Text] [Related]
20. Design and synthesis of (4E)-4-(4-substitutedbenzylideneamino)-3-substituted-2,3-dihydro-2-thioxothiazole-5-carbonitrile as novel A2A receptor antagonists.
Mishra CB; Sharma D; Prakash A; Kumari N; Kumar N; Luthra PM
Bioorg Med Chem; 2013 Oct; 21(19):6077-83. PubMed ID: 23953686
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]